文献速递儿童呼吸儿童血液肿瘤与免疫

无支气管扩张或心脏病的儿童咯血:病因、复发与死亡

Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality.
PubMed 文献 · J Pediatr · 2019-09-17

该回顾性病例系列纳入2007至2017年波士顿儿童医院257例无支气管扩张、先天性心脏病等基础病的咯血住院患儿,感染是最常见病因(n=122),肿瘤和血小板减少与更高死亡风险相关,气管造口与更高复发风险相关。

要点

  • 感染是无严重心肺基础病患儿咯血最常见病因(n=122/257)。
  • 肿瘤和血小板减少分别与更高死亡风险相关(OR 15.8和5.9)。
  • 气管造口与更高复发风险相关(OR 6.3),但死亡风险更低(OR 0.4)。

核心结论

  • 感染是无严重基础肺病或心脏病患儿咯血的最常见病因。
  • 肿瘤和/或血小板减少相关的咯血与死亡风险相关,气管造口与复发风险相关。

研究设计与样本

  • 回顾性病例系列,纳入2007年1月1日至2017年6月1日波士顿儿童医院住院期间记录咯血的全部患者。
  • 排除支气管扩张、先天性心脏病、原发性肺动脉高压、声门以上出血、校正胎龄38周前咯血、呕血、异物和外伤患者。
  • 共257例符合标准并纳入分析,并按凝血状态进行特征描述。

主要发现

  • 最常见的咯血病因为感染(n=122)、肿瘤(n=58)和其他诊断(n=49)。
  • 感染患者复发率为28%,全因死亡率为12%。
  • 肿瘤患者复发 odds 更低(OR 0.3,P = .012),但死亡 odds 更高(OR 15.8,P < .001)。
  • 血小板减少患者复发 odds 更低(OR 0.2,P = .005),但死亡 odds 更高(OR 5.9,P < .001)。
  • 气管造口患者复发 odds 更高(OR 6.3,P < .001),但死亡 odds 更低(OR 0.4,P = .042)。

临床怎么用

  • 对无支气管扩张或心脏病的咯血患儿,应首先评估感染病因。
  • 对合并肿瘤或血小板减少的咯血患儿,需警惕死亡风险。
  • 对气管造口患儿,需关注咯血复发风险。

局限性

  • 本研究为回顾性病例系列,仅纳入单中心住院患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the etiologies of hemoptysis in patients without pre-existing bronchiectasis or cardiac disease; to assess odds of recurrent hemoptysis by diagnostic category; and to assess odds of mortality by diagnostic category. STUDY DESIGN: This retrospective case series included all patients with hemoptysis documented during an admission to Boston Children's Hospital from January 1, 2007 to June 1, 2017. Patients with bronchiectasis, congenital heart disease, primary pulmonary hypertension, bleeding above the glottis, hemoptysis before 38 weeks of corrected gestational age, hematemesis, foreign body, and trauma were excluded. Patients were also characterized by coagulation status. Primary outcomes were recurrent hemoptysis and death. Univariate analysis was performed to determine ORs for recurrence and death per diagnostic category with infection as the reference category. RESULTS: In total, 257 patients met study criteria and were analyzed. The most common causes of hemoptysis were infection (n = 122), neoplasm (n = 58), and other diagnoses (n = 49). Of the patients with infection, recurrence was 28% and all-cause mortality was 12%. Neoplasm had lower odds of recurrence (OR 0.3, P = .012) but higher odds of mortality (OR 15.8, P < .001). Thrombocytopenia had lower odds of recurrence (OR 0.2, P = .005) but higher odds of mortality (OR 5.9, P < .001). Patients with a tracheostomy had higher odds of recurrence (OR 6.3, P < .001), but lower odds of death (OR 0.4, P = .042). CONCLUSIONS: This study confirms that infection is the most common cause of hemoptysis in patients without severe underlying pulmonary or cardiac disease. Hemoptysis associated with neoplasm and/or thrombocytopenia confers mortality risk. Tracheostomy confers risk of recurrence. Future prospective research on diagnoses associated with hemoptysis is warranted.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Chiel L, Welsh S, Andren K, et al. Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality. J Pediatr. 2019. PMID: 31540762. doi:10.1016/j.jpeds.2019.07.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。